Sign in

PharmaCampus Münster

@pharmacampus-ms.bsky.social
20 followers 16 following 4 posts
PostsRepliesMedia
Reposted by PharmaCampus Münster
M. Bermúdez @bermudez-lab.bsky.social · 15/01/2026
Different agonists activate the receptor through specific activation trajectories. We demonstrate this effect in living cells with a novel type of biosensor. www.nature.com/articles/s41...
nature.com
Ligand-specific activation trajectories dictate GPCR signalling in cells - Nature
Different agonists produce equilibria of at least four distinct active states of the G-protein-bound M2 muscarinic acetylcholine receptor, each with a different ability to activate G proteins.
021
Reposted by PharmaCampus Münster
M. Bermúdez @bermudez-lab.bsky.social · 01/01/2026
In our novel study, we report well-validated models for opioid peptide binding at the atypical chemokine receptor 3 to understand their ligand promiscuity and to provide starting points for structure-based drug design. #compchem pubs.acs.org/doi/full/10....
pubs.acs.org
Deciphering Opioid Peptide Binding Modes at Atypical Chemokine Receptor 3
ACKR3 is a class A G protein-coupled receptor that is considered as an atypical chemokine receptor. It does not activate G proteins but efficiently recruits β-arrestin and mediates ligand internalizat...
072
Reposted by PharmaCampus Münster
M. Bermúdez @bermudez-lab.bsky.social · 02/10/2025
Here, we present MDPath, a novel tool to study allosteric communication pathways within protein structures: Unraveling Allosteric Communication Paths of Drug Targets through Molecular Dynamics Simulations. pubs.acs.org/doi/10.1021/...
pubs.acs.org
MDPath: Unraveling Allosteric Communication Paths of Drug Targets through Molecular Dynamics Simulations
Understanding allosteric communication in proteins remains a critical challenge for structure-based, rational drug design. We present MDPath, a Python toolkit for analyzing allosteric communication paths in molecular dynamics simulations using NMI-based analysis. We demonstrate MDPath’s ability to identify both established and novel GPCR allosteric mechanisms using the β2-adrenoceptor, adenosine A2A receptor, and μ-opioid receptor as model systems. The toolkit reveals ligand-specific allosteric effects in β2-adrenoceptor and MOR, illustrating how protein–ligand interactions drive conformational changes. Analysis of ABL1 kinase in complex with allosteric and orthosteric inhibitors demonstrates the broader applicability of the approach. Ultimately, MDPath provides an open-source framework for mapping allosteric communication within proteins, advancing structure-based drug design (https://github.com/wolberlab/mdpath).
022
Reposted by PharmaCampus Münster
Department of Chemistry and Pharmacy, Münster @chempharmms.bsky.social · 02/10/2025
Congratulations to Thomas Schmidt @pharmacampus-ms.bsky.social on receiving the Innovation Award of the "Gesellschaft für Phytotherapie e. V." for his outstanding research @uni-muenster.de on using topical arnica tincture to treat cutaneous leishmaniasis. Publication: doi.org/10.1371/jour...
Privat-Dozentin Silke Cameron übergibt im Welfenschloss Hann. Münden den Innovationspreis der Gesellschaft für Phytotherapie an Professor Doktor Thomas Schmidt. Copyright: IPBP.
042
PharmaCampus Münster @pharmacampus-ms.bsky.social · 08/05/2025
On April 29, the University of Münster’s PharmaCampus hosted the formal farewell ceremony for pharmacy graduates who successfully passed the Second Pharmaceutical Examination. uni.ms/f9ms1
030
PharmaCampus Münster @pharmacampus-ms.bsky.social · 08/05/2025
The Medicinal Chemistry Section of the German Chemical Society awards the 2025 Medicinal/Pharmaceutical Chemistry Doctoral Prize to Dr Wenxin Felix Zhu. In his doctoral thesis, Dr Zhu established the potassium channel Slack as a new drug target. Congratulations to Dr Wenxin Felix Zhu!
030
PharmaCampus Münster @pharmacampus-ms.bsky.social · 08/05/2025
At this year's ‘Frontiers in Medicinal Chemistry’ conference, Dr Dmitrii Kalinin was awarded the 2025 Innovation Award for Medicinal/Pharmaceutical Chemistry. Congratulations to Dr. Dmitrii Kalinin!
030
PharmaCampus Münster @pharmacampus-ms.bsky.social · 20/01/2025
The next DPhG-lecture tomorrow will focus on current developments for Morbus Parkinson. Prof. Dr. Holger Stark from @hhu.bsky.social will talk about recent aspects of diagnosis and treatment. Join us at PharmaCampus (Corrensstr., big lecture hall, 18:15) or online: uni.ms/tn0q7
uni.ms
DPhG hybrid - Morbus Parkinson im aktuellen Licht – von der Diagnostik zur Therapie
063